Oxidative Medicine and Cellular Longevity

Research Article

Photobiomodulation Therapy Combined with a Static Magnetic Field Applied in Different Moments Enhances Performance and Accelerates Muscle Recovery in CrossFit® Athletes: A Randomized, Triple-Blind, Placebo-Controlled Crossover Trial

Table 2

Absolute values about functional capacity, rating of perceived exertion (RPE), muscle damage, inflammatory activity, and oxidative stress ().
VariablesIntervention ()Baseline ()Immediately after the WOD ()Immediately after the intervention ()1 h ()24 h ()48 h ()
Performance on functional test (free squat reps)Placebo67.64 (±6.09)—62.09 (±8.15)66.36 (±5.55)66.45 (±6.98)65.82 (±7.45)
PBMT-sMF before65.73(±7.32)—63.27 (±9.02)66.18 (±5.31)67.09 (±5.50)67.73 (±6.15)
PBMT-sMF after63.09 (±8.04)—63.82 (±6.69)65.27 (±6.53)67.18 (±6.93)67.45 (±6.64)
PBMT-sMF before and after65.91 (±6.82)—61.55 (±9.17)65.64 (±6.31)67.45 (±6.28)67.45 (±5.20)
Exertion subjective perception (RPE cardiorespiratory)Placebo5.81 (±12.10)80.00 (±27.84)14.81 (±18.24)8.54 (±13.99)2.54 (±5.04)1.92 (±4.35)
PBMT-sMF before1.31 (±1.11)81.85 (±19.98)13.31 (±13.46)2.38 (±4.44)3.00 (±6.36)2.52 (±8.27)
PBMT-sMF after3.85 (±5.96)84.23 (±19.88)15.92 (±21.41)4.77 (±88.89)1.15 (±3.00)1.00 (±2.83)
PBMT-sMF before and after5.00 (±7.70)78.20 (±26.96)16.80 (±21.18)7.60 (±12.06)2.00 (±6.32)0.70 (±1.64)
Exertion subjective perception (RPE muscles)Placebo9.27 (±8.81)81.92 (±29.08)27.92 (±23.85)10.58 (±11.35)12.19 (±11.79)11.38 (±15.98)
PBMT-sMF before5.27 (±8.37)91.54 (±17.37)24.77 (±20.00)13.54 (±20.01)12.77 (±11.59)9.22 (±12.87)
PBMT-sMF after10.35 (±15.00)90.38 (±15.34)26.85 (±19.78)16.25 (±15.89)7.35 (±6.88)6.85 (±14.18)
PBMT-sMF before and after9.20 (±15.33)82.00 (±20.44)33.30 (±26.22)11.45 (±12.95)8.50 (±11.65)5.75 (±6.49)
Muscle damage (CK (lμ/l))Placebo145.29 (±115.80)——170.52 (±130.38)207.93 (±167.92)198.94 (±192.23)
PBMT-sMF before158.60 (±127.39)——168.70 (±123.27)189.04 (±157.47)127.65 (±104.57)
PBMT-sMF after153.10 (±120.34)——163.01 (±125.30)170.74 (±115.94)110.45 (±99.73)
PBMT-sMF before and after190.38 (±188.89)——199.21 (±209.30)198.78 (±203.80)145.16 (±149.84)
Inflammation (IL-6 (pg/ml))Placebo8.95 (±2.76)——13.43 (±2.88)11.94 (±3.05)12.78 (±3.93)
PBMT-sMF before8.16 (±1.51)——10.68 (±1.80)7.79 (±1.44)aa9.38 (±2.17)a
PBMT-sMF after8.76 (±2.50)——12.43 (±3.43)8.08 (±2.72)aa10.24 (±2.55)
PBMT-sMF before and after8.58 (±2.06)——12.77 (±3.24)8.25 (±2.04)aa9.75 (±2.59)a
Oxidative stress (TBARS) (nmol/ml)Placebo3.20 (±0.28)——4.38 (±0.37)5.41 (±0.64)6.66 (±0.17)
PBMT-sMF before3.36 (±0.33)——4.57 (±0.30)5.44 (±0.26)4.61 (±0.31)aaaabbbb
PBMT-sMF after3.32 (±0.18)——4.60 (±0.32)5.53 (±0.33)4.68 (±0.30)aaaabbbb
PBMT-sMF before and after3.46 (±0.38)——4.49 (±0.34)5.52 (±0.29)6.45 (±0.35)
Oxidative stress (carbonylated proteins) (nmol of DNPH/g/dl of protein)Placebo4.97 (±0.55)——5.98 (±0.32)6.52 (±0.72)6.73 (±0.64)
PBMT-sMF before5.22 (±0.21)——5.94 (±0.36)5.66 (±0.50)aabb5.76 (±0.54)aaaabbbb
PBMT-sMF after5.12 (±0.40)——5.91 (±0.36)5.62 (±0.22)aabb5.81 (±0.50)aa bbbb
PBMT-sMF before and after5.01 (±0.35)——6.14 (±0.53)6.55 (±0.64)6.93 (±0.66)
Antioxidant activity (CAT) (U CAT/g of protein)Placebo4.39 (±0.56)——4.60 (±0.40)3.67 (±0.41)3.27 (±0.21)
PBMT-sMF before4.41 (±0.58)——5.07 (±0.32)a5.28 (±0.43)aaaabbbb5.27 (±0.19)aaaabbbb
PBMT-sMF after4.37 (±0.40)——5.06 (±0.45)a5.36 (±0.47)aaaabbbb5.19 (±0.23)aaaabbbb
PBMT-sMF before and after4.18 (±0.52)——4.66 (±0.39)3.54 (±0.42)3.38 (±0.25)
Antioxidant activity (SOD) (U SOD/g of protein)Placebo3.36 (±0.34)——3.45 (±0.52)3.04 (±0.46)2.91 (±0.30)
PBMT-sMF before3.50 (±0.48)——3.61 (±0.63)4.01 (±0.38)aaaabbbb4.12 (±0.34aaaabbbb
PBMT-sMF after3.44 (±0.36)——3.55 (±0.41)3.97 (±0.31)aaaabbb4.32 (±0.54)aaaabbbb
PBMT-sMF before and after3.27 (±0.29)——3.32 (±0.55)3.20 (±0.51)2.89 (±0.24)
Values are expressed as the (±SD). Compared to placebo: a, aa, and aaaa. Compared to PBMT-sMF before and after WOD: bb, bbb, and bbbb.